Harmony Biosciences Holdings Inc (HRMY) Company Profile & Statistics

Harmony Biosciences Holdings Inc
HRMY
(Nasdaq - US)
Closed
29.75
+0.23 (+0.78%)
in:usd•As of: Apr 16, 2024 15:59 UTC -4
Open
29.40
High
30.60
Low
29.32

About Harmony Biosciences Holdings Inc

CEO

Jeffrey M. Dayno

Headquarters

630 w. germantown pike, suite 215

plymouth meeting, pa 19462, united states

Auditor

Deloitte & Touche LLP

Employees

246

Share Holders

Website

www.harmonybiosciences.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.

Harmony Biosciences Holdings Inc Statistics

Valuation Measures

Market Capitalization ²	1.69B
Enterprise Value	1.57B
Enterprise Value/EBITDA (ttm)	7.28
Price to Earnings Ratio (ttm)	13.91
Price to Book (mrq)	3.70
Price to Sales (ttm)	2.88
Price to Cash (ytd)	11.31

Profitability

Gross Margin (ttm)	79.54%
Operating Margin (ttm)	22.16%
Profit Margin (ttm)	22.53%
Return on Equity (ttm)	27.49%
Return on Invested Capital (ttm)	19.77%
Return on Assets (ttm)	16.83%

Income Statement

Revenue (ttm)	582.02M
Revenue Per Share (ttm)	10.25
Gross Profit (ttm)	460.79M
EBITDA (ttm)³	215.95M
Net Income Avi to Common (ttm)	128.85M
Diluted EPS (ttm)	2.12

Share Statistics

Beta (5Y Monthly)	0.73
52-Week Change	-10.79%
S&P500 52-Week Change	21.68%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	56.77M
Dividend Yield	0.00%
Float ⁴	37.09M
% Held by Insiders	34.70%
% Held by Institutions	86.23%

Balance Sheet

Total Cash (mrq)	353.46M
Total Cash Per Share (mrq)	6.23
Total Debt (mrq)	193.57M
Total Debt/Equity (mrq)	41.45%
Current Ratio (mrq)	2.75%
Quick Ratio (mrq)	2.72%
Book Value Per Share (mrq)	8.23

Cash Flow

Operating Cash Flow Per Share (ytd)	3.63
Free Cash Flow (ytd)	219.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Harmony Biosciences Holdings Inc

Trade With A Regulated Broker